The vaccines market is projected to grow at a CAGR of 7.0%

NEXT STORY
Generex Declares NEW Dividend RECORD DATE: Monday, February 17, 2020
PREV STORY
Amicus Therapeutics Announces Presentations and Posters at 16th Annual WORLDSymposium™ 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Basilea reports positive interim results from phase 2 study FIDES-01 for derazantinib in FGFR2 gene mutation- or amplification-positive patients with bile duct cancer (iCCA)

author_avatar
NASDAQ Market News

Plus Therapeutics, Inc. Announces Pricing Of $15 Million Underwritten Public Offering

author_avatar
NASDAQ Market News

Teleflex Announces Third Quarter 2021 Earnings Conference Call Information

author_avatar
NASDAQ Market News